Systematic Review of Pragmatic Randomised Control Trials Assessing the Effectiveness of Professional Pharmacy Services in Community Pharmacies

Overview

Journal BMC Health Serv Res

Publisher Biomed Central

Specialty Health Services

Date 2021 Feb 18

PMID 33596906

Citations 5

Authors

R Varas-Doval

L Saez-Benito

M A Gastelurrutia

S I Benrimoj

V Garcia-Cardenas

F Martinez-Martinez

Affiliations

Soon will be listed here.

Abstract

Background: Implementation of Professional Pharmacy Services (PPSs) requires a demonstration of the service's impact (efficacy) and its effectiveness. Several systematic reviews and randomised controlled trials (RCT) have shown the efficacy of PPSs in patient's outcomes in community pharmacy. There is, however, a need to determine the level of evidence on the effectiveness of PPSs in daily practice by means of pragmatic trials. To identify and analyse pragmatic RCTs that measure the effectiveness of PPSs in clinical, economic and humanistic outcomes in the community pharmacy setting.

Methods: A systematic search was undertaken in MEDLINE, EMBASE, the Cochrane Library and SCIELO. The search was performed on January 31, 2020. Papers were assessed against the following inclusion criteria (1) The intervention could be defined as a PPS; (2) Undertaken in a community pharmacy setting; (3) Was an original paper; (4) Reported quantitative measures of at least one health outcome indicator (ECHO model); (5) The design was considered as a pragmatic RCT, that is, it fulfilled 3 predefined attributes. External validity was analyzed with PRECIS- 2 tool.

Results: The search strategy retrieved 1,587 papers. A total of 12 pragmatic RCTs assessing 5 different types of PPSs were included. Nine out of the 12 papers showed positive statistically significant differences in one or more of the primary outcomes (clinical, economic or humanistic) that could be associated with the following PPS: Smoking cessation, Dispensing/Adherence service, Independent prescribing and MTM. No paper reported on cost-effectiveness outcomes.

Conclusions: There is limited available evidence on the effectiveness of community-based PPS. Pragmatic RCTs to evaluate clinical, humanistic and economic outcomes of PPS are needed.

Citing Articles

Bridging the gap: Enhancing pharmacist-physiscian collaboration through the provision of comprehensive medication reviews in community pharmacy.

Sanchez-Molina A, Benrimoj S, Ferri-Garcia R, Martinez-Martinez F, Gastelurrutia M, Amador-Fernandez N Explor Res Clin Soc Pharm. 2025; 17:100555.

PMID: 39896175 PMC: 11787040. DOI: 10.1016/j.rcsop.2024.100555.

Analysis of the characteristics and the degree of pragmatism exhibited by pragmatic-labelled trials of antineoplastic treatments.

Saesen R, Depreytere K, Krupianskaya K, Langeweg J, Verheecke J, Lacombe D BMC Med Res Methodol. 2023; 23(1):148.

PMID: 37355603 PMC: 10290324. DOI: 10.1186/s12874-023-01975-9.

Pharmacists' chronic disease management in chronic obstructive pulmonary disease: Effect on health services utilization.

Makhinova T, Johnson J, Minhas-Sandhu J, Necyk C, Bhutani M, Eurich D J Manag Care Spec Pharm. 2023; 29(6):671-679.

PMID: 37276041 PMC: 10388007. DOI: 10.18553/jmcp.2023.29.6.671.

Clinical pharmacy services are reimbursed in Germany: challenges of real world implementation remain.

Schulz M, Griese-Mammen N, Muller U Int J Clin Pharm. 2022; 45(1):245-249.

PMID: 36394784 PMC: 9938802. DOI: 10.1007/s11096-022-01492-7.

Clinical and Humanistic Outcomes of Community Pharmacy-Based Healthcare Interventions Regarding Medication Use in Older Adults: A Systematic Review and Meta-Analysis.

Christopher C, Kc B, Blebil A, Alex D, Ibrahim M, Ismail N Healthcare (Basel). 2021; 9(11).

PMID: 34828622 PMC: 8625440. DOI: 10.3390/healthcare9111577.

References

Bradley A, Lenox-Smith A . Does adding noradrenaline reuptake inhibition to selective serotonin reuptake inhibition improve efficacy in patients with depression? A systematic review of meta-analyses and large randomised pragmatic trials. J Psychopharmacol. 2013; 27(8):740-58. DOI: 10.1177/0269881113494937. View

Holland R, Nimmo C . Transitions, part 1: beyond pharmaceutical care. Am J Health Syst Pharm. 1999; 56(17):1758-64. DOI: 10.1093/ajhp/56.17.1758. View

Tsuyuki R, Houle S, Charrois T, Kolber M, Rosenthal M, Lewanczuk R . Randomized Trial of the Effect of Pharmacist Prescribing on Improving Blood Pressure in the Community: The Alberta Clinical Trial in Optimizing Hypertension (RxACTION). Circulation. 2015; 132(2):93-100. DOI: 10.1161/CIRCULATIONAHA.115.015464. View

Zillich A, Snyder M, Frail C, Lewis J, Deshotels D, Dunham P . A randomized, controlled pragmatic trial of telephonic medication therapy management to reduce hospitalization in home health patients. Health Serv Res. 2014; 49(5):1537-54. PMC: 4177456. DOI: 10.1111/1475-6773.12176. View

Elliott R, Boyd M, Salema N, Davies J, Barber N, Mehta R . Supporting adherence for people starting a new medication for a long-term condition through community pharmacies: a pragmatic randomised controlled trial of the New Medicine Service. BMJ Qual Saf. 2015; 25(10):747-58. DOI: 10.1136/bmjqs-2015-004400. View

Oladapo A, Barner J, Rascati K . The need for more evidence-based studies to justify the economic value for the provision of medication therapy management and other clinical pharmacy services. Clin Ther. 2012; 34(11):2196-9. DOI: 10.1016/j.clinthera.2012.10.002. View

Treweek S, Zwarenstein M . Making trials matter: pragmatic and explanatory trials and the problem of applicability. Trials. 2009; 10:37. PMC: 2700087. DOI: 10.1186/1745-6215-10-37. View

Costello M, Sproule B, Victor J, Leatherdale S, Zawertailo L, Selby P . Effectiveness of pharmacist counseling combined with nicotine replacement therapy: a pragmatic randomized trial with 6,987 smokers. Cancer Causes Control. 2010; 22(2):167-80. DOI: 10.1007/s10552-010-9672-9. View

Oliveira D, Brummel A, Miller D . Medication therapy management: 10 years of experience in a large integrated health care system. J Manag Care Pharm. 2010; 16(3):185-95. PMC: 10437567. DOI: 10.18553/jmcp.2010.16.3.185. View

10.

DeZeeuw E, Coleman A, Nahata M . Impact of telephonic comprehensive medication reviews on patient outcomes. Am J Manag Care. 2018; 24(2):e54-e58. View

11.

Planas L, Crosby K, Farmer K, Harrison D . Evaluation of a diabetes management program using selected HEDIS measures. J Am Pharm Assoc (2003). 2012; 52(6):e130-8. DOI: 10.1331/JAPhA.2012.11148. View

12.

Roberts A, Benrimoj S, Chen T, Williams K, Hopp T, Aslani P . Understanding practice change in community pharmacy: a qualitative study in Australia. Res Social Adm Pharm. 2006; 1(4):546-64. DOI: 10.1016/j.sapharm.2005.09.003. View

13.

Perraudin C, Bugnon O, Pelletier-Fleury N . Expanding professional pharmacy services in European community setting: Is it cost-effective? A systematic review for health policy considerations. Health Policy. 2017; 120(12):1350-1362. DOI: 10.1016/j.healthpol.2016.09.013. View

14.

Tunis S, Stryer D, Clancy C . Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. JAMA. 2003; 290(12):1624-32. DOI: 10.1001/jama.290.12.1624. View

15.

Yaghoubi M, Mansell K, Vatanparastc H, Steeves M, Zeng W, Farag M . Effects of Pharmacy-Based Interventions on the Control and Management of Diabetes in Adults: A Systematic Review and Meta-Analysis. Can J Diabetes. 2017; 41(6):628-641. DOI: 10.1016/j.jcjd.2017.09.014. View

16.

Tommelein E, Mehuys E, Van Hees T, Adriaens E, van Bortel L, Christiaens T . Effectiveness of pharmaceutical care for patients with chronic obstructive pulmonary disease (PHARMACOP): a randomized controlled trial. Br J Clin Pharmacol. 2013; 77(5):756-66. PMC: 4004396. DOI: 10.1111/bcp.12242. View

17.

Tosh G, Soares-Weiser K, Adams C . Pragmatic vs explanatory trials: the pragmascope tool to help measure differences in protocols of mental health randomized controlled trials. Dialogues Clin Neurosci. 2011; 13(2):209-15. PMC: 3182001. View

18.

Kozma C, Reeder C, Schulz R . Economic, clinical, and humanistic outcomes: a planning model for pharmacoeconomic research. Clin Ther. 1993; 15(6):1121-32; discussion 1120. View

19.

Rubio-Valera M, Pujol M, Fernandez A, Penarrubia-Maria M, Trave P, Lopez Del Hoyo Y . Corrigendum to: "Evaluation of a pharmacist intervention on patients initiating pharmacological treatment for depression: A randomized controlled superiority trial" [Eur. Neuropsychopharmacol. 23(2013)1057-1066]. Eur Neuropsychopharmacol. 2016; 26(6):1085. DOI: 10.1016/j.euroneuro.2016.02.016. View

20.

Salgado T, Rosenthal M, Coe A, Kaefer T, Dixon D, Farris K . Primary healthcare policy and vision for community pharmacy and pharmacists in the United States. Pharm Pract (Granada). 2020; 18(3):2160. PMC: 7523559. DOI: 10.18549/PharmPract.2020.3.2160. View